Trustees of the University of Pennsylvania

Trustees of the University of Pennsylvania was paid $84.02M by Medicaid between Jan 2018 and Dec 2024, across 582 billing codes. Its largest line is G0378, Hospital observation service, per hour — 17% of everything it billed.

33Billing provider infoTRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
PHILADELPHIA, PA 19104

33aNPI1851370910assigned 01/16/2006

33bProvider typeCommunity/Behavioral Health Agency

28Total paid$84.02M

24GClaims1,205,865

24DCodes billed582

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Community/Behavioral Health Agency providers in Pennsylvania

Rank by total paid#3 of 517

Median peer was paid$1.23M

This provider vs. median68×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	6,545	$96K
2019	10,244	$151K
2020	174,072	$10.62M
2021	489,596	$38.06M
2022	149,257	$13.31M
2023	169,690	$11.33M
2024incomplete	206,461	$10.44M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0378	Hospital observation service, per hour	17%	11,903	10,557	$14.43M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	11%	43,424	41,464	$9.60M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	11%	43,363	40,923	$9.52M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	11%	43,322	40,949	$9.30M
J2350	Injection, ocrelizumab, 1 mg	7.6%	1,080	1,001	$6.40M
A0431	Ambulance service, conventional air services, transport, one way (rotary wing)	2.6%	706	622	$2.20M
H0013	Alcohol and/or drug services; acute detoxification (residential addiction program outpatient)	2.5%	5,168	1,446	$2.12M
J9271	Injection, pembrolizumab, 1 mg	2.4%	1,833	1,481	$2.00M
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	2.2%	1,724	1,387	$1.84M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	2.0%	695	662	$1.67M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.3%	15,094	13,965	$1.13M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.0%	6,270	4,239	$869K

570 more codes

A9555	Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries	<1%	254	$749K
H2011	Crisis intervention service, per 15 minutes	<1%	1,098	$706K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	3,886	$671K
77386		<1%	1,862	$525K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	1,376	$512K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	3,586	$501K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	1,708	$496K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	340	$409K
78815	Positron emission tomography (PET) for limited area imaging	<1%	493	$395K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	514	$392K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	570	$383K
74183		<1%	794	$356K
36415	Collection of venous blood by venipuncture	<1%	109,199	$337K
99235		<1%	303	$311K
70450	Computed tomography, head or brain; without contrast material	<1%	3,276	$299K
72197		<1%	588	$297K
A0436	Rotary wing air mileage, per statute mile	<1%	663	$294K
J9144	Injection, daratumumab, 10 mg and hyaluronidase-fihj	<1%	624	$288K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	2,893	$282K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	995	$267K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	292	$253K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	65,060	$250K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	2,416	$248K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	3,938	$243K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	12,963	$230K
80048	Basic metabolic panel (calcium, ionized)	<1%	46,218	$226K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	4,178	$224K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	1,182	$215K
78431		<1%	226	$210K
36430		<1%	1,692	$197K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	10,474	$196K
80053	Comprehensive metabolic panel	<1%	27,282	$190K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	21,483	$182K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	1,390	$181K
OP250		<1%	4,350	$171K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	870	$165K
72141		<1%	571	$161K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	590	$159K
93325		<1%	479	$151K
76830	Ultrasound, transvaginal	<1%	2,317	$143K
A0427	Emergency ambulance ride, advanced life support	<1%	305	$141K
J9299	Injection, nivolumab, 1 mg	<1%	69	$139K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	407	$138K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	3,617	$134K
76801		<1%	2,375	$129K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	6,417	$128K
59025	Fetal non-stress test	<1%	7,170	$125K
T1015	A visit at a community health center or clinic (one all-in rate)	<1%	5,465	$123K
71250		<1%	1,597	$122K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	539	$120K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,432	$117K
85027		<1%	19,253	$117K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,659	$114K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	5,883	$113K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	549	$113K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	902	$112K
77066	Tomosynthesis, mammo	<1%	932	$110K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	1,311	$110K
96375	Therapeutic injection; each additional sequential IV push	<1%	6,638	$109K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	1,303	$106K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	221	$104K
81329		<1%	1,492	$102K
J9035	Injection, bevacizumab, 10 mg	<1%	20	$99K
36591		<1%	1,022	$98K
84443	Thyroid stimulating hormone (TSH)	<1%	6,905	$97K
72156		<1%	322	$97K
77412		<1%	1,498	$96K
96361	Intravenous infusion, hydration; each additional hour	<1%	6,764	$93K
71046	Radiologic examination, chest; 2 views	<1%	6,454	$93K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	1,235	$88K
96415		<1%	1,809	$88K
77338		<1%	81	$86K
J1756	Injection, iron sucrose, 1 mg	<1%	3,939	$86K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	13,548	$86K
OP710		<1%	642	$84K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	2,415	$83K
72157		<1%	300	$83K
J9395	Injection, fulvestrant, 25 mg	<1%	145	$83K
83735		<1%	23,914	$82K
76642		<1%	1,395	$82K
70543		<1%	181	$82K
77387		<1%	1,230	$81K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	407	$81K
76818		<1%	824	$79K
73221		<1%	280	$79K
95811		<1%	147	$79K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	1,114	$79K
87536		<1%	998	$78K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	3,948	$78K
36592		<1%	124	$78K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	806	$77K
96417		<1%	1,102	$74K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	10,588	$72K
86902		<1%	660	$70K
76536		<1%	1,009	$67K
80061	Lipid panel	<1%	6,764	$65K
72125	Computed tomography, cervical spine; without contrast material	<1%	626	$65K
77063	Screening digital breast tomosynthesis, bilateral	<1%	2,405	$64K
77336		<1%	1,231	$64K
82803		<1%	4,457	$64K
77334		<1%	472	$64K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	486	$63K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	2,415	$62K
86900		<1%	8,867	$59K
70486		<1%	519	$57K
86850		<1%	7,087	$56K
80076		<1%	13,043	$56K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	359	$56K
96376		<1%	1,259	$54K
77301		<1%	72	$54K
84484		<1%	5,915	$51K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	2,346	$49K
93971		<1%	829	$49K
J2785	Injection, regadenoson, 0.1 mg	<1%	1,193	$49K
19083		<1%	80	$48K
76820		<1%	1,216	$48K
95708		<1%	317	$48K
86803		<1%	3,046	$47K
83880		<1%	2,378	$47K
36512		<1%	552	$46K
94729		<1%	1,212	$45K
86480		<1%	815	$45K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	1,564	$44K
77065	Tomosynthesis, mammo	<1%	487	$44K
70491		<1%	430	$44K
72158		<1%	149	$44K
36593		<1%	171	$44K
83036	Hemoglobin; glycosylated (A1C)	<1%	9,399	$43K
80197		<1%	3,917	$41K
94010		<1%	2,534	$41K
86360		<1%	907	$41K
86832		<1%	593	$40K
74178		<1%	148	$40K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	3,163	$39K
70544		<1%	182	$39K
72146		<1%	185	$38K
74174		<1%	168	$37K
86833		<1%	595	$37K
71275	Computed tomographic angiography, chest, with contrast material	<1%	232	$37K
76770		<1%	666	$37K
86790		<1%	133	$37K
93356		<1%	390	$36K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	6,975	$36K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	5,226	$35K
87086	Culture, bacterial; quantitative colony count, urine	<1%	6,846	$35K
70496		<1%	217	$34K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	858	$33K
73630		<1%	2,089	$32K
86359		<1%	920	$32K
93017		<1%	566	$32K
94726		<1%	964	$32K
93970		<1%	291	$32K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	784	$31K
85610		<1%	11,324	$31K
43235		<1%	67	$31K
95700		<1%	148	$30K
Q3014	Telehealth originating site facility fee	<1%	10,281	$29K
93975		<1%	309	$29K
77300		<1%	464	$29K
96411		<1%	429	$29K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	87	$29K
81025		<1%	10,137	$29K
86901		<1%	7,327	$28K
93320		<1%	483	$28K
84100		<1%	9,139	$28K
36561		<1%	12	$27K
77062		<1%	893	$27K
82728		<1%	2,772	$27K
82784		<1%	1,464	$26K
10005		<1%	45	$26K
76819	Fetal biophysical profile; without non-stress testing	<1%	336	$26K
84702		<1%	2,463	$26K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	1,741	$25K
95886		<1%	545	$25K
77290		<1%	327	$25K
85730		<1%	5,969	$25K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	8,889	$25K
77295		<1%	70	$24K
87088		<1%	4,934	$23K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	88	$23K
71045	Radiologic examination, chest; single view	<1%	3,830	$23K
84466		<1%	2,238	$23K
76813		<1%	306	$23K
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	<1%	406	$23K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	3,208	$23K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	1,311	$22K
70498		<1%	155	$22K
84134		<1%	1,343	$21K
77080		<1%	412	$21K
76376		<1%	544	$20K
73564		<1%	913	$20K
80050	General health panel	<1%	538	$20K
83605		<1%	4,489	$20K
A0434	Specialty care transport (sct)	<1%	13	$20K
83970		<1%	719	$19K
88185		<1%	136	$19K
83690		<1%	6,920	$19K
77049		<1%	73	$19K
87340		<1%	1,897	$19K
74240		<1%	314	$18K
86592		<1%	6,406	$18K
58558		<1%	13	$18K
87653		<1%	650	$17K
93923		<1%	311	$17K
J9070	Cyclophosphamide, 100 mg	<1%	194	$17K
86762		<1%	1,196	$17K
96367		<1%	1,002	$17K
82330		<1%	3,663	$16K
86923		<1%	331	$16K
77280		<1%	397	$16K
73030		<1%	883	$16K
82607		<1%	1,731	$15K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	80	$15K
72100		<1%	620	$15K
81003		<1%	8,972	$15K
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	123	$15K
83540		<1%	2,430	$15K
84153		<1%	928	$15K
95911		<1%	171	$14K
82570		<1%	3,074	$14K
77061		<1%	462	$14K
85007		<1%	4,788	$14K
82375		<1%	3,645	$14K
88173		<1%	147	$14K
87497		<1%	613	$14K
G0277	Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval	<1%	41	$13K
83020		<1%	1,839	$13K
78306		<1%	177	$12K
A0888	Noncovered ambulance mileage, per mile (e.g., for miles traveled beyond closest appropriate facility)	<1%	1,106	$12K
73610		<1%	668	$12K
86141		<1%	1,364	$12K
73562		<1%	540	$11K
73130		<1%	853	$11K
J1453	Injection, fosaprepitant, 1 mg	<1%	892	$11K
76377		<1%	491	$11K
G0399	Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation	<1%	12	$11K
82947		<1%	5,127	$11K
81001		<1%	4,832	$11K
A0429	Emergency ambulance ride, basic life support	<1%	42	$11K
83883		<1%	603	$11K
OP370		<1%	80	$11K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	104	$10K
72110		<1%	333	$10K
96416		<1%	62	$10K
82105		<1%	855	$10K
93880		<1%	95	$10K
88313		<1%	180	$10K
73502		<1%	400	$10K
86704		<1%	794	$10K
83516		<1%	489	$9K
87631		<1%	149	$9K
C1769	Guide wire	<1%	533	$9K
76870		<1%	161	$9K
J3489	Injection, zoledronic acid, 1 mg	<1%	173	$9K
87522	Neg quan hep c or qual rna	<1%	345	$9K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	460	$9K
87799		<1%	327	$9K
88321		<1%	186	$8K
84403		<1%	496	$8K
82962		<1%	8,388	$8K
86706		<1%	1,058	$8K
88360		<1%	209	$8K
86160		<1%	647	$8K
93505		<1%	21	$8K
96402		<1%	322	$8K
86922		<1%	479	$8K
82043		<1%	1,346	$8K
95816		<1%	215	$7K
83615		<1%	2,038	$7K
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	693	$7K
86300		<1%	423	$7K
87077		<1%	1,688	$7K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	83	$7K
72040		<1%	332	$7K
86787		<1%	532	$7K
95910		<1%	90	$7K
81479	Unlisted molecular pathology procedure	<1%	42	$6K
82746		<1%	816	$6K
J9045	Injection, carboplatin, 50 mg	<1%	1,201	$6K
75561		<1%	13	$6K
80320		<1%	894	$6K
80364		<1%	388	$6K
86038		<1%	502	$6K
83050		<1%	3,550	$6K
86147		<1%	103	$6K
73521		<1%	196	$6K
87186		<1%	1,256	$5K
84439		<1%	884	$5K
31575		<1%	37	$5K
85652		<1%	2,162	$5K
86235		<1%	144	$5K
J8540	Dexamethasone, oral, 0.25 mg	<1%	8,722	$5K
73110		<1%	396	$5K
73560		<1%	239	$5K
82550		<1%	1,057	$5K
87517		<1%	148	$5K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	16,207	$5K
72195		<1%	16	$5K
84146		<1%	264	$5K
84165		<1%	700	$4K
86146		<1%	103	$4K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	3,373	$4K
87040		<1%	602	$4K
85379		<1%	869	$4K
82977		<1%	580	$4K
82248		<1%	863	$4K
96523		<1%	320	$4K
49083		<1%	15	$4K
86140		<1%	1,575	$4K
84156		<1%	1,752	$4K
82670		<1%	257	$4K
78434		<1%	215	$4K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	95	$4K
88341		<1%	193	$4K
86355		<1%	129	$4K
83520		<1%	250	$4K
10060		<1%	28	$4K
87070		<1%	1,060	$4K
94618		<1%	272	$3K
74246		<1%	69	$3K
88342		<1%	349	$3K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	568	$3K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	2,627	$3K
87081		<1%	1,044	$3K
82378		<1%	408	$3K
86334		<1%	235	$3K
88184		<1%	160	$3K
77470		<1%	62	$3K
84436		<1%	570	$3K
74220		<1%	98	$3K
70549		<1%	13	$3K
90715		<1%	895	$3K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	906	$3K
74019		<1%	150	$3K
J9267	Injection, paclitaxel, 1 mg	<1%	923	$3K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	5,509	$3K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	131	$3K
86225		<1%	224	$3K
86304		<1%	216	$3K
76000		<1%	93	$3K
A0425	Ground mileage, per statute mile	<1%	213	$3K
84479		<1%	554	$3K
70487		<1%	26	$3K
72131		<1%	25	$3K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	551	$3K
88307		<1%	229	$3K
84550		<1%	752	$3K
88177		<1%	30	$3K
81000		<1%	805	$3K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	60	$3K
84402		<1%	122	$2K
83001		<1%	206	$2K
88172		<1%	31	$2K
80353		<1%	341	$2K
76882		<1%	187	$2K
76937		<1%	267	$2K
84207		<1%	97	$2K
87205		<1%	962	$2K
96401		<1%	30	$2K
74018		<1%	145	$2K
87467		<1%	332	$2K
J1170	Injection, hydromorphone, up to 4 mg	<1%	5,228	$2K
86800		<1%	177	$2K
86708		<1%	219	$2K
84295		<1%	3,341	$2K
85045		<1%	674	$2K
73080		<1%	197	$2K
72070		<1%	85	$2K
84478		<1%	390	$2K
88112		<1%	169	$2K
87506		<1%	14	$2K
73590		<1%	150	$2K
86301		<1%	176	$2K
93308		<1%	136	$2K
81351		<1%	12	$2K
84432		<1%	112	$2K
74230		<1%	50	$2K
82565		<1%	801	$1K
81015		<1%	876	$1K
84480		<1%	238	$1K
86431		<1%	229	$1K
J2997	Injection, alteplase recombinant, 1 mg	<1%	470	$1K
C1729	Catheter, drainage	<1%	43	$1K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	165	$1K
J2704	Injection, propofol, 10 mg	<1%	7,135	$1K
78264		<1%	13	$1K
82533		<1%	156	$1K
92133		<1%	84	$1K
83921		<1%	103	$1K
86735		<1%	38	$1K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	3,655	$1K
82150		<1%	326	$1K
92083		<1%	46	$1K
83002		<1%	94	$1K
85018		<1%	2,783	$1K
93296		<1%	246	$1K
82247		<1%	303	$1K
72050		<1%	30	$1K
84425		<1%	248	$1K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	13,077	$1K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	4,354	$999.67
85613		<1%	102	$994.25
81513		<1%	159	$993.49
96368		<1%	154	$961.56
94060		<1%	41	$941.52
73552		<1%	47	$896.55
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	7,009	$895.06
95819		<1%	31	$879.96
86200		<1%	90	$878.54
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	13,091	$828.47
84132		<1%	1,392	$825.96
76942		<1%	29	$793.21
82274		<1%	332	$792.32
73120		<1%	65	$790.78
80177		<1%	77	$787.51
86618		<1%	30	$785.57
88312		<1%	64	$738.75
84255		<1%	12	$737.55
84460		<1%	282	$736.84
95909		<1%	12	$718.24
36000		<1%	296	$706.93
86255		<1%	74	$684.42
73090		<1%	62	$678.67
85660		<1%	347	$653.59
86765		<1%	66	$639.62
84450		<1%	249	$615.62
J2270	Injection, morphine sulfate, up to 10 mg	<1%	3,717	$611.06
OP270		<1%	71	$611.02
G0008	Administration of influenza virus vaccine	<1%	175	$610.56
82951		<1%	69	$601.45
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	26	$582.00
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	4,875	$576.24
J0640	Injection, leucovorin calcium, per 50 mg	<1%	104	$567.24
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	2,826	$549.46
87481		<1%	156	$543.35
90686		<1%	80	$541.56
86593		<1%	121	$540.31
97802		<1%	43	$532.22
87529		<1%	45	$514.70
82088		<1%	26	$513.87
95885		<1%	12	$507.24
81050		<1%	86	$472.00
87015		<1%	196	$451.16
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	997	$445.66
J1940	Injection, furosemide, up to 20 mg	<1%	1,348	$416.53
84075		<1%	196	$414.46
73140		<1%	39	$413.27
J3490	Unclassified drugs	<1%	4,031	$409.25
80164		<1%	28	$409.13
82040		<1%	152	$399.32
86870		<1%	80	$389.53
84630		<1%	39	$378.61
87493		<1%	30	$377.36
80354		<1%	12	$366.29
83021		<1%	27	$364.15
82010		<1%	201	$363.27
J0780	Injection, prochlorperazine, up to 10 mg	<1%	688	$359.42
J3480	Injection, potassium chloride, per 2 meq	<1%	1,017	$348.82
87328		<1%	27	$347.41
J1644	Injection, heparin sodium, per 1000 units	<1%	1,946	$333.27
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,753	$314.94
86077		<1%	15	$305.78
84481		<1%	12	$304.76
94680		<1%	12	$301.74
51798		<1%	59	$299.44
82435		<1%	287	$296.41
80143		<1%	70	$294.43
87116		<1%	144	$286.48
87102		<1%	111	$270.48
77333		<1%	15	$263.18
80179		<1%	62	$252.36
84166		<1%	15	$249.40
84155		<1%	98	$248.69
82785		<1%	15	$230.74
92134		<1%	42	$227.82
92557		<1%	16	$227.13
80325		<1%	28	$222.78
85008		<1%	370	$217.02
73060		<1%	13	$215.76
11102		<1%	38	$214.99
86780		<1%	29	$214.02
86769		<1%	14	$199.47
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,689	$197.16
82465		<1%	76	$193.98
89050		<1%	122	$185.03
99201		<1%	164	$177.54
82525		<1%	24	$175.59
85014		<1%	307	$173.34
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	872	$171.61
J1815	Injection, insulin, per 5 units	<1%	1,012	$162.11
J2060	Injection, lorazepam, 2 mg	<1%	1,514	$158.61
90662		<1%	36	$158.34
82103		<1%	24	$158.18
82104		<1%	24	$157.00
94200		<1%	12	$152.96
89051		<1%	50	$148.67
83012		<1%	28	$145.79
82310		<1%	31	$144.95
J3370	Injection, vancomycin hcl, 500 mg	<1%	84	$129.97
85384		<1%	28	$126.96
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	3,802	$115.83
86309		<1%	14	$114.25
87206		<1%	145	$114.11
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	179	$109.76
87329		<1%	29	$101.08
88311		<1%	17	$100.83
86376		<1%	13	$100.76
72170		<1%	15	$97.73
82390		<1%	14	$86.48
J0690	Injection, cefazolin sodium, 500 mg	<1%	506	$85.15
82952		<1%	42	$83.73
J9190	Injection, fluorouracil, 500 mg	<1%	236	$74.92
87046		<1%	44	$69.36
J1630	Injection, haloperidol, up to 5 mg	<1%	650	$60.44
84157		<1%	12	$42.39
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	13	$39.59
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	16	$34.10
87147		<1%	24	$28.90
90837	Psychotherapy session, about an hour	<1%	204	$26.84
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	<1%	14	$26.64
80329		<1%	12	$23.19
C9113	Injection, pantoprazole sodium, per vial	<1%	548	$19.20
J1650	Injection, enoxaparin sodium, 10 mg	<1%	1,222	$16.24
S5000	Prescription drug, generic	<1%	652	$3.31
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	661	$1.53
S0028	Injection, famotidine, 20 mg	<1%	2,909	$1.17
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	874	$0.02
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	0%	1,868	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	129	$0.00
J1920	Injection, labetalol hydrochloride, 5 mg	0%	212	$0.00
J1790	Injection, droperidol, up to 5 mg	0%	421	$0.00
J0360	Injection, hydralazine hcl, up to 20 mg	0%	69	$0.00
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	0%	3,353	$0.00
J0461	Injection, atropine sulfate, 0.01 mg	0%	81	$0.00
J0613	Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg	0%	641	$0.00
83521		0%	28	$0.00
Q5121	Injection, infliximab-axxq, biosimilar, (avsola), 10 mg	0%	232	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	101	$0.00
J0456	Injection, azithromycin, 500 mg	0%	64	$0.00
J2469	Injection, palonosetron hcl, 25 mcg	0%	86	$0.00
J0185	Injection, aprepitant, 1 mg	0%	549	$0.00
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	0%	168	$0.00
J0611	Injection, calcium gluconate (wg critical care), per 10 ml	0%	80	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	313	$0.00
C2627	Catheter, suprapubic/cystoscopic	0%	43	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	28	$0.00
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	0%	29	$0.00
J2471	Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg	0%	29	$0.00
88304		0%	15	$0.00
J7612	Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg	0%	18	$0.00
J1953	Injection, levetiracetam, 10 mg	0%	217	$0.00
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	0%	693	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	571	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	14	$0.00
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	0%	132	$0.00
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	0%	320	$0.00
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	0%	45	$0.00
J3380	Injection, vedolizumab, intravenous, 1 mg	0%	26	$0.00
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	0%	105	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	123	$0.00
J9000	Injection, doxorubicin hydrochloride, 10 mg	0%	13	$0.00
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	0%	31	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	330	$0.00
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	0%	15	$0.00
J9206	Injection, irinotecan, 20 mg	0%	67	$0.00
J9060	Injection, cisplatin, powder or solution, 10 mg	0%	30	$0.00
J0897	Injection, denosumab, 1 mg	0%	26	$0.00
J3250	Injection, trimethobenzamide hcl, up to 200 mg	0%	30	$0.00
J1956	Injection, levofloxacin, 250 mg	0%	18	$0.00
J1230	Injection, methadone hcl, up to 10 mg	0%	17	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCCORMICK, THOMAS (VICE PRESIDENT FINANCE)

Same official

Other billing entities under MCCORMICK, THOMAS

Full network →

Provider	Location	Paid
The Pennsylvania Hospital of the University of Pennsylvania Health Sys	Phila, PA	$25.68M
Presbyterian Medical Center of the University of Pennsylvania Health S	Philadelphia, PA	$23.27M
Hall-Mercer Cmh-Mrc of Pennsylvania Hosp	Philadelphia, PA	$14.08M
Hall-Mercer Cmh-Mrc of PA Hosp	Phila, PA	$6.82M
Hospital of University of Pennsylvania	Phila, PA	$2.61M
Penn Presbyterian Medical CTR Detox Rehab	Phila, PA	$1.60M
Penn Presybyterian Medical Center	Phila, PA	$1.48M
The Pennsylvania Hospital of the University of Pennsylvania Health Sys	Philadelphia, PA	$69K
Thomas E Mccormick, MD, PC	Rutland, VT	$22K
Presbyterian Medical Center of the University of Pennsylvania Health S	Philadelphia, PA	$11K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.